Article Details
Retrieved on: 2018-04-23 17:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>It's a different course than the one Revolution laid out three years ago after emerging from venture capital firm <b>Third Rock Ventures</b>. Revolution used technology licensed from the University of Illinois at Urbana-Champaign to develop the antifungal compound that it unveiled at the time, along with a $45 ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here